Skip to main content
SpringerLink
Log in

Treat cutaneous lupus erythematosus primarily with topical corticosteroids and systemic antimalarials

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

References

  1. Fabbri P, Cardinali C, Giomi B, et al. Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol 2003; 4(7): 449–65

    Article  PubMed  Google Scholar 

  2. Reid C. Drug treatment of cutaneous lupus. Am J Clin Dermatol 2000; 1(6): 375–9

    Article  PubMed  CAS  Google Scholar 

  3. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for cutaneous lupus erythematosus. J Am Acad Dermatol 1996; 34: 830–6

    Article  PubMed  CAS  Google Scholar 

  4. Kimberly RE, Burke WA. Treatment of localized discoid lupus erythematosus with tazarotene. J Am Acad Dermatol 1999; 41: 1049–50

    Article  Google Scholar 

  5. Werth V. Current treatment of cutaneous lupus erythematosus. Dermatol Online J 2001; 7(1): 2

    PubMed  CAS  Google Scholar 

  6. Sontheimer RD. Questions answered and a $1 million question raised concerning lupus erythematosus tumidus: is routine laboratory surveillance testing during treatment with hydroxychloroquine for skin disease really necessary? Arch Dermatol 2000; 136: 1044–9

    Article  PubMed  CAS  Google Scholar 

  7. Pelle MT, Werth VP. Thalidomide in cutaneous lupus erythematosus. Am J Clin Dermatol 2003; 4(6): 379–87

    Article  PubMed  Google Scholar 

  8. Ordi-Ros J, Cortes F, Cucurull E, et al. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. J Rheumatol 2000; 27: 1429–33

    PubMed  CAS  Google Scholar 

  9. Kyriakis KP, Kontochristopoulos GJ, Panteleos D. Experience with low-dose thalidomide therapy in chronic discoid lupus erythematous. Int J Dermatol 2000; 39: 218–22

    Article  PubMed  CAS  Google Scholar 

  10. Delaporte E, Catteau B, Sabbagh N, et al. Treatment of discoid lupus erythematosus with sulfasalazine. Ann Dermatol Venereol 1997; 124: 151–6

    PubMed  CAS  Google Scholar 

  11. Dalziel K, Going G, Cartwright PH, et al. Treatment of chronic discoid lupus erythematosus with an oral compound (auranofin). Br J Dermatol 1986; 115: 211–6

    Article  PubMed  CAS  Google Scholar 

  12. Versapuech J, Beylot-Barry M, Doutre MS, et al. Subacute cutaneous lupus: evolutive and therapeutic features of a series of 24 cases. Presse Med 2000; 29: 1596–9

    PubMed  CAS  Google Scholar 

  13. Doutre MS, Beylot-Barry M, Beylot C. Subacute cutaneous lupus erythematosus. Presse Med 2000; 29: 1311–6

    PubMed  CAS  Google Scholar 

  14. Callen JP, Klein J. Subacute cutaneous lupus erythematosus: clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients. Arthritis Rheum 1988; 31: 1007–13

    Article  PubMed  CAS  Google Scholar 

  15. Kuhn A, Specker C, Ruzicka T, et al. Methotrexate treatment for refractory subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2002; 46: 600–3

    Article  PubMed  Google Scholar 

  16. Bohm L, Uerlich M, Bauer R. Rapid improvement of subacute cutaneous lupus erythematosus with low-dose methotrexate. Dermatology 1997; 194: 307–8

    Article  PubMed  CAS  Google Scholar 

  17. Goyal S, Nousari HC. Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol 2001; 45: 142–4

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treat cutaneous lupus erythematosus primarily with topical corticosteroids and systemic antimalarials. Drugs Ther. Perspect 20, 11–14 (2004). https://doi.org/10.2165/00042310-200420070-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200420070-00004

Search

Navigation